Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)

China flag China · Delayed Price · Currency is CNY
41.62
+0.02 (0.05%)
At close: Jan 23, 2026
-16.74%
Market Cap17.39B
Revenue (ttm)3.70B
Net Income (ttm)474.39M
Shares Out417.75M
EPS (ttm)1.21
PE Ratio34.52
Forward PE35.80
Dividend0.32 (0.76%)
Ex-Dividend DateOct 24, 2025
Volume1,988,137
Average Volume2,532,222
Open41.63
Previous Close41.60
Day's Range41.40 - 41.69
52-Week Range35.00 - 49.99
Betan/a
RSI54.92
Earnings DateMar 28, 2026

About SHA:603014

Shandong Weigao Blood Purification Products Co., Ltd. engages in the research and development, production, and sale of blood purification medical products in China. It offers dialyzers, dialysis machines, hemodialysis machines, A.V. fistula needle sets, extracorporeal blood circuits, bloodlines, and plasma separators; peritoneal dialysis (PD) solutions; and PD consumables, such as bag free set, catheter joints, and transfer tube sets. The company was founded in 2004 and is based in Weihai, China. [Read more]

Sector Healthcare
Founded 2004
Country China
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603014
Full Company Profile

Financial Performance

In 2024, SHA:603014's revenue was 3.60 billion, an increase of 2.03% compared to the previous year's 3.53 billion. Earnings were 449.37 million, an increase of 1.65%.

Financial Statements